Novartis IgAN information in New England Magazine of Medication display Fabhalta® slowed kidney serve as decline via 49.3%
Fabhalta reduced probability of development to kidney failure via 43% in APPLAUSE-IgAN…
New SPRAVATO® (esketamine nasal spray) information fortify tough effectiveness and display sturdy impact for medication resistant melancholy in a real-world atmosphere
Johnson & Johnson items findings from the most important Eu real-world dataset…
